InsideTrading SEC Form 4 insider trades

Stocks

ACET Adicet Bio, Inc.

Healthcare · Market cap: $26.0M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $289.6K 2022-Q2: bought $0, sold $327.6K 2022-Q3: bought $0, sold $1.6M 2022-Q4: bought $0, sold $2.1M 2023-Q1: bought $0, sold $117.8K 2023-Q2: bought $3.7M, sold $0 2023-Q3: bought $7.8K, sold $15.3K 2023-Q4: bought $7.3K, sold $0 2024-Q1: bought $15.0M, sold $0 2024-Q2: bought $0, sold $8.4K 2024-Q3: bought $0, sold $0 2024-Q4: bought $0, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $5.0M, sold $0 2026-Q1: bought $1.6M, sold $0 2026-Q2: bought $0, sold $674.8K 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $15.0M) Sold, below the line (largest quarter $2.1M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$289.6K
2022-Q2$0$327.6K
2022-Q3$0$1.6M
2022-Q4$0$2.1M
2023-Q1$0$117.8K
2023-Q2$3.7M$0
2023-Q3$7.8K$15.3K
2023-Q4$7.3K$0
2024-Q1$15.0M$0
2024-Q2$0$8.4K
2024-Q3$0$0
2024-Q4$0$0
2025-Q1$0$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$5.0M$0
2026-Q1$1.6M$0
2026-Q2$0$674.8K
2026-Q3$0$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$32.3M12 buy days
Sold$5.2M28 sell days
Net insider flow+$27.1Mnet buying · 5 years
Latest trade2026-04-08ORBIMED ADVISORS LLC
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-04-08 Sell ORBIMED ADVISORS LLC 10% owner 72,939 $6.42 $468.1K 2
2026-04-07 Sell ORBIMED ADVISORS LLC 10% owner 31,719 $6.52 $206.8K 2
2026-02-20 Buy RA Capital Healthcare Fund LP 10% owner 74,751 $7.27 $543.4K 1
2026-02-19 Buy RA Capital Healthcare Fund LP 10% owner 74,268 $7.21 $535.5K 1
2026-02-18 Buy RA Capital Healthcare Fund LP 10% owner 74,577 $7.04 $525.0K 1
2025-10-08 Buy ORBIMED ADVISORS LLC 10% owner 5,000,000 $1.00 $5.0M 2
2024-06-05 Sell Kauffman Michael Director 5,900 $1.43 $8.4K 1
2024-01-25 Buy GORDON CARL L Director 3,125,000 $2.40 $7.5M 3
2024-01-25 Buy ORBIMED ADVISORS LLC Director 3,125,000 $2.40 $7.5M 3
2023-10-02 Buy Schor Chen CEO 5,500 $1.33 $7.3K 1
2023-09-29 Sell Schor Chen CEO 5,500 $1.36 $7.5K 1
2023-09-28 Sell Schor Chen CEO 5,500 $1.42 $7.8K 1
2023-09-28 Buy Schor Chen CEO 5,500 $1.42 $7.8K 1
2023-06-30 Buy DUBIN STEVE Director 5,000 $2.40 $12.0K 1
2023-06-27 Buy GORDON CARL L Director 875,000 $2.09 $1.8M 4
2023-06-27 Buy Chimovits Erez Director 875,000 $2.09 $1.8M 4
2023-02-15 Sell Healey Don Other C-suite 4,533 $7.57 $34.3K 1
2023-02-10 Sell Healey Don Other C-suite 10,467 $7.98 $83.5K 1
2022-11-10 Sell Schor Chen CEO 39,955 $20.30 $811.2K 2
2022-11-10 Sell Aftab Blake Other C-suite 6,967 $21.00 $146.3K 1
2022-11-07 Sell Schor Chen CEO 30,000 $19.05 $571.5K 1
2022-11-03 Sell Schor Chen CEO 24,813 $18.04 $447.6K 1
2022-11-02 Sell Schor Chen CEO 500 $18.00 $9.0K 1
2022-10-19 Sell Aftab Blake Other C-suite 8,067 $16.27 $131.3K 1
2022-10-12 Sell Aftab Blake Other C-suite 1,646 $15.40 $25.3K 1
2022-09-14 Sell Schor Chen CEO 952 $18.00 $17.1K 1
2022-09-13 Sell CEO 3,371 $18.01 $60.7K 1
2022-09-12 Sell CEO 66,947 $16.77 $1.1M 2
2022-09-09 Sell CEO 8,094 $16.51 $133.6K 1
2022-08-03 Sell Aftab Blake Other C-suite 6,968 $18.00 $125.4K 1
2022-08-01 Sell Aftab Blake Other C-suite 6,968 $16.64 $115.9K 1
2022-07-05 Sell Aftab Blake Other C-suite 1,363 $14.50 $19.8K 1
2022-04-04 Sell Galimi Francesco Other C-suite 7,979 $21.00 $167.6K 3
2022-04-01 Sell Galimi Francesco Other C-suite 7,621 $21.00 $160.0K 1
2022-03-09 Sell Jakobovits Aya Director 2,000 $14.00 $28.0K 1
2022-02-16 Sell Jakobovits Aya Director 2,000 $14.83 $29.7K 1
2022-02-09 Sell Jakobovits Aya Director 4,000 $14.03 $56.1K 1
2022-01-05 Sell Jakobovits Aya Director 4,000 $16.91 $67.7K 2
2022-01-03 Sell Jakobovits Aya Director 6,000 $18.02 $108.1K 1
2021-12-08 Buy Sinclair Andrew Director 500,000 $14.00 $7.0M 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
ORBIMED ADVISORS LLC 10% owner $14.3M $674.8K 2026-04-08
GORDON CARL L Director $9.3M $0 2024-01-25
Sinclair Andrew Director $7.0M $0 2021-12-08
Schor Chen CEO $15.1K $3.2M 2023-10-02
RA Capital Healthcare Fund LP 10% owner $1.6M $0 2026-02-20
Aftab Blake Other C-suite $0 $564.0K 2022-11-10
Galimi Francesco Other C-suite $0 $327.6K 2022-04-04
Jakobovits Aya Director $0 $289.6K 2022-03-09
Healey Don Other C-suite $0 $117.8K 2023-02-15
DUBIN STEVE Director $12.0K $0 2023-06-30
Kauffman Michael Director $0 $8.4K 2024-06-05

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2023-06-27 → 2023-06-30 3 $3.7M 57 -2.3% (+2.1% raw)-39.7% (-46.1% raw)-24.9% (-17.3% raw) closed
2018-01-30 3 $19.5M 45 +17.7% (+12.9% raw)-28.7% (-35.2% raw)-15.9% (-15.7% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.